Search research articles
Contact Us
Filters
Showing results (11-20 of 194) with videos related to
Page
of 20
Sort By:
European Urology
|
September 12, 2012
Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care
Axel Heidenreich, David Pfister
Therapeutic Advances in Urology
|
August 2, 2012
Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice
Axel Heidenreich, David Pfister
BJU International
|
January 24, 2018
Even 'low-dose' cabazitaxel requires careful and meticulous patient selection
Axel Heidenreich, David Pfister
European Urology
|
August 20, 2013
Pelvic lymphadenectomy in clinically localised prostate cancer: counting lymph nodes or dissecting primary landing zones of the prostate?
Axel Heidenreich, David Pfister
Current Opinion in Urology
|
November 15, 2019
Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease
Axel Heidenreich, David Pfister
Urologie (Heidelberg, Germany)
|
September 15, 2025
[Retroperitoneal lymphadenectomy (RPLND) for the treatment of testicular germ cell tumors-open or robotic? Pro open surgery : RPLND in the management of testis cancer]
Axel Heidenreich, David Pfister
Biotechnology and Bioengineering
|
January 13, 2016
Integrated process for high conversion and high yield protein PEGylation
David Pfister, Massimo Morbidelli
Aktuelle Urologie
|
September 2, 2022
David Pfister, Timo Ohrmann
Oncology Research and Treatment
|
March 3, 2017
HIV-Associated Urogenital Malignancies
Marcus Hentrich, David Pfister
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 19, 2015
Extended pelvic lymphadenectomy in prostate cancer: Practice makes perfect
Axel Heidenreich, David Pfister
Page
of 20
Search research articles
Search
Showing results (11-20 of 194) with videos related to
Sort By:
Page
of 20
European Urology
|
September 12, 2012
Treatment decisions for metastatic castration-resistant prostate cancer progressing after docetaxel chemotherapy: the role of cabazitaxel in the continuum of care
Axel Heidenreich, David Pfister
Therapeutic Advances in Urology
|
August 2, 2012
Retroperitoneal lymphadenectomy and resection for testicular cancer: an update on best practice
Axel Heidenreich, David Pfister
BJU International
|
January 24, 2018
Even 'low-dose' cabazitaxel requires careful and meticulous patient selection
Axel Heidenreich, David Pfister
European Urology
|
August 20, 2013
Pelvic lymphadenectomy in clinically localised prostate cancer: counting lymph nodes or dissecting primary landing zones of the prostate?
Axel Heidenreich, David Pfister
Current Opinion in Urology
|
November 15, 2019
Radical cytoreductive prostatectomy in men with prostate cancer and oligometastatic disease
Axel Heidenreich, David Pfister
Urologie (Heidelberg, Germany)
|
September 15, 2025
[Retroperitoneal lymphadenectomy (RPLND) for the treatment of testicular germ cell tumors-open or robotic? Pro open surgery : RPLND in the management of testis cancer]
Axel Heidenreich, David Pfister
Biotechnology and Bioengineering
|
January 13, 2016
Integrated process for high conversion and high yield protein PEGylation
David Pfister, Massimo Morbidelli
Aktuelle Urologie
|
September 2, 2022
David Pfister, Timo Ohrmann
Oncology Research and Treatment
|
March 3, 2017
HIV-Associated Urogenital Malignancies
Marcus Hentrich, David Pfister
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada
|
June 19, 2015
Extended pelvic lymphadenectomy in prostate cancer: Practice makes perfect
Axel Heidenreich, David Pfister
Page
of 20